June Zhang

Prof. June Zhang


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 July 2023 in Journal of the American Medical Directors Association
Verified
Journal Article
Closed access
LSLu Shao
Lu Shao
YSYing Shi
Ying Shi
XXXi-Yan Xie
Xi-Yan Xie
ZWZhong Wang
Zhong Wang
ZWZhang-An Wang
Zhang-An Wang
JZJune Zhang
June Zhang

2 June 2021 in BMC Geriatrics
Verified
Journal Article
Open access
PDF file
XZXiao-Ming Zhang
Xiao-Ming Zhang
DCDenghong Chen
Denghong Chen
XXXiaohua Xie
Xiaohua Xie
JZJune Zhang
June Zhang
YZYingchun Zeng
Yingchun Zeng
ACAndy Sk Cheng
Andy Sk Cheng
Background: The evidence of sarcopenia based on CT-scan as an important prognostic factor for critically ill patients has not seen consistent results. To determine the impact of sarcopenia on mortality in critically ill patients, we performed a systematic review and meta-analysis to quantify the association between sarcopenia and mortality. Methods: We searched studies from the literature of PubMed, EMBASE, and Cochrane Library from database inception to June 15, 2020. All observational studies exploring the relationship between sarcopenia based on CT-scan and mortality in critically ill patients were included. The search and data analysis were independently conducted by two investigators. A meta-analysis was performed using STATA Version 14.0 software using a fixed-effects model. Results: Fourteen studies with a total of 3,249 participants were included in our meta-analysis. The pooled prevalence of sarcopenia among critically ill patients was 41 % (95 % CI:33-49 %). Critically ill patients with sarcopenia in the intensive care unit have an increased risk of mortality compared to critically ill patients without sarcopenia (OR = 2.28, 95 %CI: 1.83–2.83; P < 0.001; I2 = 22.1 %). In addition, a subgroup analysis found that sarcopenia was associated with high risk of mortality when defining sarcopenia by total psoas muscle area (TPA, OR = 3.12,95 %CI:1.71–5.70), skeletal muscle index (SMI, OR = 2.16,95 %CI:1.60–2.90), skeletal muscle area (SMA, OR = 2.29, 95 %CI:1.37–3.83), and masseter muscle(OR = 2.08, 95 %CI:1.15–3.77). Furthermore, critically ill patients with sarcopenia have an increased risk of mortality regardless of mortality types such as in-hospital mortality (OR = 1.99, 95 %CI:1.45–2.73), 30-day mortality(OR = 2.08, 95 %CI:1.36–3.19), and 1-year mortality (OR = 3.23, 95 %CI:2.08 -5.00). Conclusions: Sarcopenia increases the risk of mortality in critical illness. Identifying the risk factors of sarcopenia should be routine in clinical assessments and offering corresponding interventions may help medical staff achieve good patient outcomes in ICU departments.

1 June 2021 in European Journal of Oncology Nursing
Verified
Journal Article
Closed access
RJRuiqi Jin
Ruiqi Jin
TXTingting Xie
Tingting Xie
LZLijuan Zhang
Lijuan Zhang
NGNi Gong
Ni Gong
JZJune Zhang
June Zhang

1 May 2021 in Epilepsy & Behavior
Verified
Journal Article
Closed access
YSYing Shi
Ying Shi
SLSha Liu
Sha Liu
JWJingjing Wang
Jingjing Wang
CLChen Li
Chen Li
JZJune Zhang
June Zhang

1 April 2021 in European Journal of Oncology Nursing
Verified
Journal Article
Closed access
LHLe Jian He
Le Jian He
MZMei Chun Zheng
Mei Chun Zheng
FWFrances Kam Yuet Wong
Frances Kam Yuet Wong
JYJin Ying
Jin Ying
JZJune Zhang
June Zhang

1 December 2020 in European Journal of Oncology Nursing
Verified
Journal Article
Closed access
MYMeng Yang
Meng Yang
LLLi Liu
Li Liu
CGChun-E Gan
Chun-E Gan
LQLi-Hong Qiu
Li-Hong Qiu
XJXiao-Juan Jiang
Xiao-Juan Jiang
JZJune Zhang
June Zhang